de Nonneville, A.; Finetti, P.; Adelaide, J.; Lambaudie, É.; Viens, P.; Gonçalves, A.; Birnbaum, D.; Mamessier, E.; Bertucci, F.
A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers. Cancers 2019, 11, 1158.
https://doi.org/10.3390/cancers11081158
AMA Style
de Nonneville A, Finetti P, Adelaide J, Lambaudie É, Viens P, Gonçalves A, Birnbaum D, Mamessier E, Bertucci F.
A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers. Cancers. 2019; 11(8):1158.
https://doi.org/10.3390/cancers11081158
Chicago/Turabian Style
de Nonneville, Alexandre, Pascal Finetti, José Adelaide, Éric Lambaudie, Patrice Viens, Anthony Gonçalves, Daniel Birnbaum, Emilie Mamessier, and François Bertucci.
2019. "A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers" Cancers 11, no. 8: 1158.
https://doi.org/10.3390/cancers11081158
APA Style
de Nonneville, A., Finetti, P., Adelaide, J., Lambaudie, É., Viens, P., Gonçalves, A., Birnbaum, D., Mamessier, E., & Bertucci, F.
(2019). A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers. Cancers, 11(8), 1158.
https://doi.org/10.3390/cancers11081158